We found that breast cancers with low expression of the crosstalk molecules, Sonic Hedgehog (SHH) or Slit homolog 2 (SLIT2), have significantly shorter relapse-free survivals than those with high expression (Supplemental Figure S5). This evidence concerns the gene SHH and breast carcinoma.